Cardiff Oncology, Inc.
ONVANSERTIB FOR INHIBITING NON-ADRENERGIC CONTRACTION OF SMOOTH MUSCLE AND PROSTATE CELL PROLIFERATION

Last updated:

Abstract:

Provided is a method of treating benign prostatic hyperplasia (BPH) in a patient. Also provided is a method of inhibiting non-adrenergic contraction of a smooth muscle. Additionally provided is a method of inhibiting proliferation of human prostate cells.

Status:
Application
Type:

Utility

Filling date:

25 Feb 2020

Issue date:

12 May 2022